The latest news from British Patient Capital
Press release 04 November 2024
British Patient Capital – Full Year Results for the period ending 31 March 2024
Driving long-term growth: British Patient Capital’s total fund and co-investment commitments reach £2.3 billion, retaining its position as the UK’s largest domestic investor in venture and venture growth capital. Total assets under management have now reached £3.125 billion.
Filter Close filters
Displaying 61 - 70 of 95 results
Filter news
Showing 61 - 70 of 95 results
-
British Patient Capital invests in graphene-specialist ParagrafPress release
01 March 2022 -
British Patient Capital commits $20 million to Balderton Capital VIIIPress release
16 December 2021 -
British Patient Capital announces €30m commitment to Partech Growth IIPress release
30 November 2021 -
British Patient Capital invests in Quell Therapeutics’ $156m funding round through Future Fund: BreakthroughPress release
29 November 2021 -
British Patient Capital invests in Thought Machine’s Series C funding roundPress release
29 November 2021 -
British Patient Capital – Full Year Results for the period ending 31 March 2021Press release
18 November 2021 -
British Patient Capital invests in Ultraleap’s £60m funding round through Future Fund: BreakthroughPress release
17 November 2021 -
British Patient Capital Commits €25m to Nauta Capital’s fifth fundPress release
02 November 2021 -
British Patient Capital invests in accuRx, as part of its £27.5m Series B fundraisingPress release
15 September 2021 -
Future Fund: Breakthrough Now Open for Investor ApplicationsPress release
20 July 2021